Pricing Log in Create free account

Charles River Laboratories International, Inc. (CRL) vs ICON PLC (ICLR)

Charles River Laboratories International, Inc. and ICON PLC are both Diagnostics & Research companies. Charles River Laboratories International, Inc. and ICON PLC are of similar size ($15.1B and $14.9B). ICON PLC trades at the lower P/E: 34.5× against 300×. ICON PLC grew revenue faster over the last twelve months: 1.82% against −1.16%. ICON PLC has the higher net margin (5.45% vs 1.01%) and the higher return on invested capital (3.84% vs 1.81%). Across the 22 metrics below, ICON PLC leads on 18 and Charles River Laboratories International, Inc. on 4.

Valuation

Metric CRL ICLR Diagnostics & Research median
P/E 300.09 34.48 34.52
P/S 3.77 1.88 4.24
P/B 4.64 1.70 3.42
Price to free cash flow 37.56 18.10 33.51
EV/EBITDA 31.20 17.86 23.44
EV/Sales 4.34 2.35 5.18
Earnings yield 0.33% 2.90% (1.50%)
Free cash flow yield 2.66% 5.53% 0.00%

Profitability

Metric CRL ICLR Diagnostics & Research median
Gross margin 33.33% 23.43% 48.32%
Operating margin 4.00% 8.72% (5.68%)
Net margin 1.01% 5.45% (4.10%)
Free cash flow margin 10.05% 10.41% 0.00%
Return on equity 1.21% 4.86% 0.00%
Return on assets 0.54% 2.74% (6.05%)
Return on invested capital 1.81% 3.84% 0.00%

Growth

Metric CRL ICLR Diagnostics & Research median
Revenue growth (TTM) (1.16%) 1.82% 8.99%
EPS growth (last fiscal year) (1,555.00%) (67.42%) 20.36%
Revenue growth, 5-year CAGR 6.55% 24.15% 7.30%
Net income growth, 5-year CAGR 0.00% (7.15%) 0.00%

Health

Metric CRL ICLR Diagnostics & Research median
Debt to equity 0.76 0.37 0.01
Current ratio 1.41 1.32 2.27
Net debt to EBITDA 3.24 3.34 0.68

Dividend

Metric CRL ICLR Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric CRL ICLR Diagnostics & Research median
Market cap 14.94b 15.11b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack